arrow
S

Sher Zaman Safi

Peking University
H指数:38
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of expression profiles of APOA4; CEACAM1; CD147; DJ-1/PARK7; Gamma-synuclein; S100A1; and Stathmin-1 in urothelial carcinomas using immunohistochemical assays

评估ApoA4;CEACAM1;CD147;DJ-1/PARK7;Gamma-synuclein;S100A1;以及Stathmin-1在尿路上皮癌中的表达谱,采用免疫组化方法。

2025-11-210
OAAI
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021

青少年和年轻人群中心力衰竭的趋势与预测:全球疾病负担研究2021的深度分析

2025-07-014
OAAI
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021

1990—2021年与年龄相关性黄斑变性相关的视力损害全球负担,以及至2050年的预测:一项针对2021年全球疾病负担研究的系统分析

2025-06-250
OA
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家在实现世卫组织终结结核病战略的2020里程碑方面取得的进展: 对全球疾病负担研究2021的系统分析

2024-07-0111
OAAI
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2022至2050 204个国家和地区的疾病负担情景: 全球疾病负担研究2021的预测分析

LANCET
IF88.5
2024-05-0179
OAAI
Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study

1990至2019亚洲癌症负担的时间模式: 全球疾病负担2019研究的系统检查

2024-02-018
OAAI
Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors

在药物设计困难和制药行业未来潜力的背景下探索人工智能和机器学习模型

METHODS
IF4.3
2023-11-018
PRE
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

六种主要免疫介导的炎性疾病的全球、地区和国家发病率: 全球疾病负担研究2019的结果

2023-10-0131
OAAI
Effectiveness of locally produced ready to use supplementary food on hemoglobin, anthropometrics, and plasma micronutrients concentrations of 6 to 23 months age children: a non-randomized community-based trial from Pakistan
2023-07-271
OAAI
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家糖尿病负担1990年2021年,以及患病率2050年预测: 全球疾病负担研究的系统分析2021

LANCET
IF88.5
2023-07-01941
OAAI